FDA Inspection 768767 — davAgen Pharmaceuticals LLC
The FDA completed an inspection of davAgen Pharmaceuticals LLC on Feb 27, 2012 in Somerset, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Feb 27, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Somerset, NJ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 3445 | 21 CFR 211.65(a) | Equipment construction - reactive surfaces |
| 4315 | 21 CFR 211.84(d)(2) | Testing Each Component for Conformity with Specs |
| 4403 | 21 CFR 211.194(b) | Test method modification records do not include |